业界指内地次批带量采购药品有望在9月底前启动
就有关内地深化医药卫生体制改革2019年重点工作任务,据《中国证券报》引述北京鼎臣管理谘询总经理史立臣表示称,以药品集中采购和使用为突破口,进一步深化医改政策制定目的是为了解决现有问题,因此,第二批带量采购有望在9月底前启动,而在政策制定後,带量采购有望全面铺开。
内地日前发布《深化医药卫生体制改革2019年重点工作任务》,明确要求研究制定15个文件,并且制定时间表和指定相应负责部门;同时,主要围绕解决看病难看病贵问题和加强医院管理等方面,提出21项具体工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.